290 related articles for article (PubMed ID: 29615472)
1. Epigenetic regulation in the tumorigenesis of MEN1-associated endocrine cell types.
Iyer S; Agarwal SK
J Mol Endocrinol; 2018 Jul; 61(1):R13-R24. PubMed ID: 29615472
[TBL] [Abstract][Full Text] [Related]
2. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
Dreijerink KMA; Timmers HTM; Brown M
Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
[TBL] [Abstract][Full Text] [Related]
3. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
5. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation by the menin pathway.
Feng Z; Ma J; Hua X
Endocr Relat Cancer; 2017 Oct; 24(10):T147-T159. PubMed ID: 28811300
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
9. A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.
Ehrlich L; Hall C; Meng F; Lairmore T; Alpini G; Glaser S
Gene Expr; 2017 Jul; 17(3):251-263. PubMed ID: 28485270
[TBL] [Abstract][Full Text] [Related]
10. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract][Full Text] [Related]
11. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.
Donati S; Ciuffi S; Marini F; Palmini G; Miglietta F; Aurilia C; Brandi ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066578
[TBL] [Abstract][Full Text] [Related]
12. The gene for multiple endocrine neoplasia type 1: recent findings.
Marx SJ; Agarwal SK; Heppner C; Kim YS; Kester MB; Goldsmith PK; Skarulis MC; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree JS; Collins FS; Chandrasekharappa SC
Bone; 1999 Jul; 25(1):119-22. PubMed ID: 10423035
[TBL] [Abstract][Full Text] [Related]
13. Menin molecular interactions: insights into normal functions and tumorigenesis.
Agarwal SK; Kennedy PA; Scacheri PC; Novotny EA; Hickman AB; Cerrato A; Rice TS; Moore JB; Rao S; Ji Y; Mateo C; Libutti SK; Oliver B; Chandrasekharappa SC; Burns AL; Collins FS; Spiegel AM; Marx SJ
Horm Metab Res; 2005 Jun; 37(6):369-74. PubMed ID: 16001329
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression in neuroendocrine tumors from patients with the MEN1 syndrome.
Dilley WG; Kalyanaraman S; Verma S; Cobb JP; Laramie JM; Lairmore TC
Mol Cancer; 2005 Feb; 4(1):9. PubMed ID: 15691381
[TBL] [Abstract][Full Text] [Related]
15. MENIN-mediated regulation of gastrin gene expression and its role in gastrinoma development.
Elvis-Offiah UB; Duan S; Merchant JL
FASEB J; 2023 May; 37(5):e22913. PubMed ID: 37078545
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
[TBL] [Abstract][Full Text] [Related]
17. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
18. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
[TBL] [Abstract][Full Text] [Related]
19. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.
Yuan Z; Sánchez Claros C; Suzuki M; Maggi EC; Kaner JD; Kinstlinger N; Gorecka J; Quinn TJ; Geha R; Corn A; Pastoriza J; Jing Q; Adem A; Wu H; Alemu G; Du YC; Zheng D; Greally JM; Libutti SK
Oncotarget; 2016 Mar; 7(11):12633-50. PubMed ID: 26871472
[TBL] [Abstract][Full Text] [Related]
20. The future: genetics advances in MEN1 therapeutic approaches and management strategies.
Agarwal SK
Endocr Relat Cancer; 2017 Oct; 24(10):T119-T134. PubMed ID: 28899949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]